As most investors are probably aware, headlines and mispricings often uncover short-term profit opportunities with stocks. I actually talked about this last month, when I compared the fundamentals and… Read More

Generic drug companies are standing on the cusp of a once-in-a-lifetime opportunity.#-ad_banner-# In the next five years, a total of $290 billion in prescription drug sales are expected to lose patent protection, making brand-name pharmaceutical companies vulnerable to generic competition. The… Read More

Concerns are often raised in isolated news stories and research reports long before a problem becomes a crisis. Warnings that real estate was overvalued, for example, fell on deaf ears until the subprime… Read More

It’s tough to retire on a 2% yield. Factor in inflation, and you’re all but guaranteed to lose money on many traditional income products, including… Read More

Investors have been wisely diversifying their portfolios to provide exposure to more than just U.S. stocks. Whether it’s emerging markets, real estate or gold bullion, a broad-based approach provides for… Read More

On Monday, Jan. 7, the U.S. Mint began taking orders for 2013 American Eagle silver coins. Officials were bracing for an onslaught of sales, but I doubt they were expecting this. By the end of the day, the Mint had sold more than 3.9 million of the 1-ounce 99.9% silver… Read More

Right now is one of the best times to invest in some of the most hated companies in U.S. history. And while they may be “hated,” they’re also some of the most successful. Their roots trace back to the corporate raiders of the 1980s. Tycoons such as Carl Icahn, Victor… Read More

Between 1841 and 1869, about half a million people flocked to the U.S. West Coast for gold. That number was so significant, the prospectors were given a nickname based on the year the migration peaked — 49ers.#-ad_banner-# While most of the 49ers didn’t find significant amounts of… Read More

Although nuclear power plants only provid about 12% of the world’s electricity production, growing energy demand put Cameco Corp. (NYSE: CCJ) in a position to benefit. The company is engaged in the exploration, development, mining, refining, conversion and fabrication of uranium for sale as… Read More

True confessions: I’ve been known to engage in chart chasing. “Chart chasing” is a nickname coined by StreetAuthority co-founder Paul Tracy to describe the practice of running to the nearest digital device to pull up a price chart whenever someone mentions a… Read More